eTS database_Shirotake et al_Molecular and Clinical Oncology 2018
收藏NIAID Data Ecosystem2026-03-10 收录
下载链接：
https://figshare.com/articles/dataset/eTS_database/6972788
下载链接
链接失效反馈官方服务：
资源简介：
The renal tumors or metastatic lesions of 127 were
evaluated by CT or MRI 90 days before molecular targeted tharapy (MTT) treatment (as baseline scans) as well
as between 30 and 90 days after MTT (as first post baseline scans). Two
urologists (HK and TO) and a radiologist (SM) blindly measured the sum of the
longest diameters (SLD) in each case, based on the Response Evaluation Criteria
in Solid Tumors (RECIST) version 1.1. Tumor shrinkage was determined
based on the change in SLD of target lesions at the first post baseline scan.
创建时间：
2018-08-16
